Abstract

The investigation of the insulin signaling cascade has revealed a broad physiologic role that extends far beyond the classical insulin target tissues—liver, muscle, and fat. The insulin-like signaling system is integrated throughout the body to coordinate systemic growth and development with peripheral and central nutrient homeostasis, fertility, and lifespan. Dysregulated insulin signaling is associated with a cohort of common systemic disorders, including obesity and dyslipidemia, cardiovascular disease and hypertension, infertility, and neurodegeneration. The insulin receptor substrates proteins—mainly Irs1 and Irs2—coordinate insulin and insulin-like growth factor signals in all tissues. The insulin-like signaling cascade through Irs2 is critical for β-cell growth, function, and survival, so similar signaling cascades coordinate insulin secretion and action. The IRS-proteins are adapter molecules that link the insulin-like receptors to common downstream signaling cascades. Recent studies reveal a variety of factors secreted from adipose tissue that inhibit insulin signaling. The tools now available to probe the insulin-like signaling cascades in healthy and diabetic tissues provide a rational platform to develop new strategies to treat insulin resistance and prevent its progression to Type 2 diabetes and neurodegeneration. Future work must better resolve the network of insulin responses that are generated in various tissues, because too much insulin action might also shorten lives.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call